$0.14
-0.01 (-6.60%)
Open$0.14
Previous Close$0.15
Day High$0.14
Day Low$0.13
52W High$4.85
52W Low$0.10
Volume—
Avg Volume60.67M
Market Cap10.07M
P/E Ratio—
EPS$-0.58
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.76M | 8.11M |
| Net Income | 881.2K | 841.9K | 1.08M |
| Profit Margin | 11.6% | 12.5% | 13.3% |
| EBITDA | 1.17M | 1.13M | 1.25M |
| Free Cash Flow | 539.3K | 438.1K | 671.3K |
| Rev Growth | -2.4% | +10.1% | +12.1% |
| Debt/Equity | 0.23 | 0.23 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |